Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss first clinical evaluation of lateral flow antigen test. Alastair talks us through the data and explains the next steps in taking the test to market.
CORRECTION: Clarification Regarding Medusa 19 Antibody Test
DirectorsTalk would like to highlight that the article from TheBusinessdesk.com has now been deleted and DirectorsTalk would also like to mention that Avacta is not involved in the antibody test produced by Medusa 19. Avacta Group